Emery-Dreifuss Muscular Dystrophy (X-Linked Emery-Dreifuss Muscular Dystrophy) Summary

195 relevant articles (2 outcomes, 5 trials/studies) found for this Disease

Description: A heterogenous group of inherited muscular dystrophy without the involvement of nervous system. The disease is characterized by MUSCULAR ATROPHY; MUSCLE WEAKNESS; CONTRACTURE of the elbows; ACHILLES TENDON; and posterior cervical muscles; with or without cardiac features. There are several INHERITANCE PATTERNS including X-linked (X CHROMOSOME), autosomal dominant, and autosomal recessive gene mutations.

Also Known As: X-Linked Emery-Dreifuss Muscular Dystrophy; Scapuloperoneal Muscular Dystrophy; Muscular Dystrophy, Emery-Dreifuss; Autosomal Dominant Emery-Dreifuss Muscular Dystrophy; Autosomal Recessive Emery-Dreifuss Muscular Dystrophy Show All >>

Key Drugs and Agents for Emery-Dreifuss Muscular Dystrophy

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:

Lamin Type A (Lamin A) : 1 outcome 1 study in 57 results : IBA
1-Phosphatidylinositol 3-Kinase (PI 3 Kinase) : 1 outcome in 1 result : IBA
Dystrophin : 1 outcome in 1 result : IBA
emerin : 2 studies in 96 results : IBA
DNA (Deoxyribonucleic Acid) : 2 studies in 7 results : IBA
Lamins : 1 study in 33 results : IBA
Proteins (Proteins, Gene) : 24 results : IBA
Triad : 9 results : FDA 1
Nuclear Proteins (Protein, Nuclear) : 5 results : IBA
lamin C : 5 results : IBA

Show All >>

Diseases Related to Emery-Dreifuss Muscular Dystrophy

Show All >>

Key Therapies for Emery-Dreifuss Muscular Dystrophy

Efficacy Chart >>